Chronic Idiopathic Constipation Drugs Market - Global Outlook and Forecast 2022-2028
Report Code: KNJ1156191 No. of Pages: 119 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Chronic Idiopathic Constipation Drugs in global, including the following market information:
Global Chronic Idiopathic Constipation Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chronic Idiopathic Constipation Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Chronic Idiopathic Constipation Drugs companies in 2021 (%)
The global Chronic Idiopathic Constipation Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chronic Idiopathic Constipation Drugs include Pfizer, Glaxosmithkline, Roche Holding AG, Sanofi, Bayer AG, Merck, Eli Lilly, Allergens and Chugai Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chronic Idiopathic Constipation Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Idiopathic Constipation Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Lubiprostone
Others
Global Chronic Idiopathic Constipation Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Chronic Idiopathic Constipation Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Chronic Idiopathic Constipation Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Idiopathic Constipation Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chronic Idiopathic Constipation Drugs revenues share in global market, 2021 (%)
Key companies Chronic Idiopathic Constipation Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Chronic Idiopathic Constipation Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Ferring International Center S.A
Synergy Pharmaceuticals
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Bausch Health
Daiichi Sankyo
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Theravance Biopharma Inc
1 Introduction to Research & Analysis Reports
1.1 Chronic Idiopathic Constipation Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Idiopathic Constipation Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Idiopathic Constipation Drugs Overall Market Size
2.1 Global Chronic Idiopathic Constipation Drugs Market Size: 2021 VS 2028
2.2 Global Chronic Idiopathic Constipation Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Chronic Idiopathic Constipation Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Chronic Idiopathic Constipation Drugs Players in Global Market
3.2 Top Global Chronic Idiopathic Constipation Drugs Companies Ranked by Revenue
3.3 Global Chronic Idiopathic Constipation Drugs Revenue by Companies
3.4 Global Chronic Idiopathic Constipation Drugs Sales by Companies
3.5 Global Chronic Idiopathic Constipation Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Chronic Idiopathic Constipation Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Chronic Idiopathic Constipation Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Chronic Idiopathic Constipation Drugs Players in Global Market
3.8.1 List of Global Tier 1 Chronic Idiopathic Constipation Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Chronic Idiopathic Constipation Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Idiopathic Constipation Drugs Market Size Markets, 2021 & 2028
4.1.2 Linaclotide
4.1.3 Lubiprostone
4.1.4 Others
4.2 By Type - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
4.2.1 By Type - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
4.2.2 By Type - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
4.2.3 By Type - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
4.3.1 By Type - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
4.3.2 By Type - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
4.3.3 By Type - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Chronic Idiopathic Constipation Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Chronic Idiopathic Constipation Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
5.2.1 By Application - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
5.2.2 By Application - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
5.2.3 By Application - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
5.3.1 By Application - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
5.3.2 By Application - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
5.3.3 By Application - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Chronic Idiopathic Constipation Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Chronic Idiopathic Constipation Drugs Market Size, 2021 & 2028
6.2 By Region - Global Chronic Idiopathic Constipation Drugs Revenue & Forecasts
6.2.1 By Region - Global Chronic Idiopathic Constipation Drugs Revenue, 2017-2022
6.2.2 By Region - Global Chronic Idiopathic Constipation Drugs Revenue, 2023-2028
6.2.3 By Region - Global Chronic Idiopathic Constipation Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Chronic Idiopathic Constipation Drugs Sales & Forecasts
6.3.1 By Region - Global Chronic Idiopathic Constipation Drugs Sales, 2017-2022
6.3.2 By Region - Global Chronic Idiopathic Constipation Drugs Sales, 2023-2028
6.3.3 By Region - Global Chronic Idiopathic Constipation Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.4.2 By Country - North America Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.4.3 US Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.4.4 Canada Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.4.5 Mexico Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.5.3 Germany Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.4 France Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.5 U.K. Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.6 Italy Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.7 Russia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.5.9 Benelux Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.6.3 China Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.4 Japan Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.5 South Korea Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.6.7 India Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.7.2 By Country - South America Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.7.3 Brazil Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.7.4 Argentina Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Chronic Idiopathic Constipation Drugs Sales, 2017-2028
6.8.3 Turkey Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.4 Israel Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
6.8.6 UAE Chronic Idiopathic Constipation Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Chronic Idiopathic Constipation Drugs Major Product Offerings
7.1.4 Pfizer Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Glaxosmithkline
7.2.1 Glaxosmithkline Corporate Summary
7.2.2 Glaxosmithkline Business Overview
7.2.3 Glaxosmithkline Chronic Idiopathic Constipation Drugs Major Product Offerings
7.2.4 Glaxosmithkline Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Glaxosmithkline Key News
7.3 Roche Holding AG
7.3.1 Roche Holding AG Corporate Summary
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Chronic Idiopathic Constipation Drugs Major Product Offerings
7.3.4 Roche Holding AG Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Roche Holding AG Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Chronic Idiopathic Constipation Drugs Major Product Offerings
7.4.4 Sanofi Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Sanofi Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Chronic Idiopathic Constipation Drugs Major Product Offerings
7.5.4 Bayer AG Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Bayer AG Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Chronic Idiopathic Constipation Drugs Major Product Offerings
7.6.4 Merck Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Chronic Idiopathic Constipation Drugs Major Product Offerings
7.7.4 Eli Lilly Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Allergens
7.8.1 Allergens Corporate Summary
7.8.2 Allergens Business Overview
7.8.3 Allergens Chronic Idiopathic Constipation Drugs Major Product Offerings
7.8.4 Allergens Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Allergens Key News
7.9 Chugai Pharmaceutical
7.9.1 Chugai Pharmaceutical Corporate Summary
7.9.2 Chugai Pharmaceutical Business Overview
7.9.3 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Major Product Offerings
7.9.4 Chugai Pharmaceutical Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Chugai Pharmaceutical Key News
7.10 Ferring International Center S.A
7.10.1 Ferring International Center S.A Corporate Summary
7.10.2 Ferring International Center S.A Business Overview
7.10.3 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Major Product Offerings
7.10.4 Ferring International Center S.A Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Ferring International Center S.A Key News
7.11 Synergy Pharmaceuticals
7.11.1 Synergy Pharmaceuticals Corporate Summary
7.11.2 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Business Overview
7.11.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Major Product Offerings
7.11.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Synergy Pharmaceuticals Key News
7.12 Salix Pharmaceuticals Ltd
7.12.1 Salix Pharmaceuticals Ltd Corporate Summary
7.12.2 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Business Overview
7.12.3 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Major Product Offerings
7.12.4 Salix Pharmaceuticals Ltd Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Salix Pharmaceuticals Ltd Key News
7.13 Sucampo Pharmaceuticals Inc
7.13.1 Sucampo Pharmaceuticals Inc Corporate Summary
7.13.2 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Business Overview
7.13.3 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.13.4 Sucampo Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Sucampo Pharmaceuticals Inc Key News
7.14 Ironwood Pharmaceuticals Inc
7.14.1 Ironwood Pharmaceuticals Inc Corporate Summary
7.14.2 Ironwood Pharmaceuticals Inc Business Overview
7.14.3 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.14.4 Ironwood Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Ironwood Pharmaceuticals Inc Key News
7.15 Bausch Health
7.15.1 Bausch Health Corporate Summary
7.15.2 Bausch Health Business Overview
7.15.3 Bausch Health Chronic Idiopathic Constipation Drugs Major Product Offerings
7.15.4 Bausch Health Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Bausch Health Key News
7.16 Daiichi Sankyo
7.16.1 Daiichi Sankyo Corporate Summary
7.16.2 Daiichi Sankyo Business Overview
7.16.3 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Major Product Offerings
7.16.4 Daiichi Sankyo Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Daiichi Sankyo Key News
7.17 Cosmo Pharmaceuticals SA
7.17.1 Cosmo Pharmaceuticals SA Corporate Summary
7.17.2 Cosmo Pharmaceuticals SA Business Overview
7.17.3 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Major Product Offerings
7.17.4 Cosmo Pharmaceuticals SA Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Cosmo Pharmaceuticals SA Key News
7.18 Progenics Pharmaceuticals Inc
7.18.1 Progenics Pharmaceuticals Inc Corporate Summary
7.18.2 Progenics Pharmaceuticals Inc Business Overview
7.18.3 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.18.4 Progenics Pharmaceuticals Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Progenics Pharmaceuticals Inc Key News
7.19 Theravance Biopharma Inc
7.19.1 Theravance Biopharma Inc Corporate Summary
7.19.2 Theravance Biopharma Inc Business Overview
7.19.3 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Major Product Offerings
7.19.4 Theravance Biopharma Inc Chronic Idiopathic Constipation Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Theravance Biopharma Inc Key News
8 Global Chronic Idiopathic Constipation Drugs Production Capacity, Analysis
8.1 Global Chronic Idiopathic Constipation Drugs Production Capacity, 2017-2028
8.2 Chronic Idiopathic Constipation Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Chronic Idiopathic Constipation Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Chronic Idiopathic Constipation Drugs Supply Chain Analysis
10.1 Chronic Idiopathic Constipation Drugs Industry Value Chain
10.2 Chronic Idiopathic Constipation Drugs Upstream Market
10.3 Chronic Idiopathic Constipation Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Chronic Idiopathic Constipation Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com